Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

7.5K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasmonic Nanocavity-Induced Degradation Pathway of Boronic Acid Biosensing Interfaces Revealed by <i>In Situ</i> Tip-Enhanced Raman Spectroscopy.

ACS nano·2026
Same author

Noninvasive Analysis of Skin Emanations during Cupping Therapy by Thin-Film Solid-Phase Microextraction and Dielectric Barrier Discharge Ionization Mass Spectrometry.

Analytical chemistry·2026
Same author

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

Molecular therapy. Advances·2026
Same author

Intestinal resident effector-memory CD4 T cells on the adaptive-innate spectrum comprise IL-18 reactivity and adaptive CMV specificity.

Science advances·2026
Same author

Tracking Protein Misfolding and Oligomerization: A Temperature-Controlled Ion Mobility-Mass Spectrometry Approach.

Analytical chemistry·2026
Same author

Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

EBioMedicine·2026

Related Experiment Video

Updated: Mar 31, 2026

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

4.0K

Integrating Functional Response and Target Binding for Mechanism-Centered Drug Screening by High-Mass MALDI-MS.

Congrui Tan1, Yu Gao2, Marcus Buggert2

  • 1Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), CH-8093 Zürich, Switzerland.

ACS Central Science
|March 30, 2026
PubMed
Summary

This study introduces a new mass spectrometry platform for drug discovery. It integrates functional and binding assays to better identify effective drug candidates for challenging targets like protein-protein interactions.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K

Related Experiment Videos

Last Updated: Mar 31, 2026

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

4.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Mass Spectrometry

Background:

  • Early drug discovery faces high failure rates due to separate functional and binding assays.
  • Distinguishing drug mechanisms for protein-protein interactions is challenging.
  • Existing methods create an information gap, hindering effective hit advancement.

Purpose of the Study:

  • To develop an integrated assay for simultaneous measurement of biochemical function and target binding.
  • To generate multidimensional pharmacological profiles for drug candidates.
  • To enable rational selection of high-quality leads for challenging drug targets.

Main Methods:

  • Developed a cross-linking matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) platform.
  • Integrated biochemical functional response and target binding into a single assay.
  • Utilized the SARS-CoV-2 RBD-ACE2 interaction and 17 drug candidates for proof-of-concept.

Main Results:

  • The platform distinguished between two otherwise indistinguishable inhibitors of the SARS-CoV-2 RBD-ACE2 interaction.
  • One inhibitor demonstrated stronger affinity and preferential ACE2 binding compared to the other.
  • Mechanistic differences correlated with improved cell viability in cellular antiviral assays.

Conclusions:

  • The developed MALDI-MS platform offers a mechanism-centered, rapid screening strategy.
  • Provides early multiparameter insight for drug lead selection.
  • Compatible with high-throughput formats for efficient drug discovery.